{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:18:29Z","timestamp":1771067909333,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.socscimed.2020.112924","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T17:39:59Z","timestamp":1584639599000},"page":"112924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Framing utility: Regulatory reform and genetic tests in the USA, 1989\u20132000"],"prefix":"10.1016","volume":"304","author":[{"given":"Steve","family":"Sturdy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.socscimed.2020.112924_bib1","first-page":"1443","article-title":"Statement of the American Society of Human Genetics on cystic fibrosis carrier screening","volume":"51","author":"American Society of Human Genetics","year":"1992","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.socscimed.2020.112924_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/gm412","article-title":"Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis\u00ae compared to Genentech's Herceptin\u00ae","volume":"5","author":"Baldwin","year":"2013","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.socscimed.2020.112924_bib3","first-page":"438","article-title":"General population screening for cystic fibrosis is premature","volume":"50","author":"Biesecker","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.socscimed.2020.112924_bib4","series-title":"Evidence-based Medical Testing: Developing Evidence-Based Reimbursement Recommendations for Tests and Markers. Report Prepared for the Dutch Health Care Insurance Board","author":"Bossuyt","year":"2011"},{"issue":"6","key":"10.1016\/j.socscimed.2020.112924_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.socscimed.2011.04.022","article-title":"Regulating diagnosis in post-genomic medicine: Re-aligning clinical judgment?","volume":"73","author":"Bourret","year":"2011","journal-title":"Soc. Sci. Med."},{"issue":"2","key":"10.1016\/j.socscimed.2020.112924_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11024-017-9324-2","article-title":"Opening the regulatory black box of clinical cancer research: transnational expertise networks and \u201cdisruptive\u201d technologies","volume":"55","author":"Cambrosio","year":"2017","journal-title":"Minerva"},{"issue":"2","key":"10.1016\/j.socscimed.2020.112924_bib7","first-page":"393","article-title":"The American society of human genetics statement on cystic fibrosis screening","volume":"46","author":"Caskey","year":"1990","journal-title":"Am. J. Hum. Genet."},{"issue":"87","key":"10.1016\/j.socscimed.2020.112924_bib8","first-page":"25928","article-title":"Notice of intent; genetic testing under the clinical laboratory improvement Amendments","volume":"65","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"Fed. Regist."},{"key":"10.1016\/j.socscimed.2020.112924_bib10","series-title":"Genetic Screening: Programs, Principles, and Research","year":"1975"},{"key":"10.1016\/j.socscimed.2020.112924_bib11","series-title":"The Gene Wars: Science, Politics and the Human Genome","author":"Cook-Deegan","year":"1994"},{"issue":"4","key":"10.1016\/j.socscimed.2020.112924_bib12","first-page":"753","article-title":"What will it take to reap the clinical benefits of pharmacogenomics?","volume":"61","author":"Evans","year":"2006","journal-title":"Food Drug Law J."},{"key":"10.1016\/j.socscimed.2020.112924_bib13","series-title":"Draft Letter to Eric T. Juengst, 5 July 1991. National Academy of Sciences Archives, Central Policy Files, DHSP","author":"Fullarton","year":"1991"},{"issue":"1","key":"10.1016\/j.socscimed.2020.112924_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15265161.2018.1544304","article-title":"Genomic contextualism: shifting the rhetoric of genetic exceptionalism","volume":"19","author":"Garrison","year":"2019","journal-title":"Am. J. Bioeth."},{"issue":"2","key":"10.1016\/j.socscimed.2020.112924_bib15","first-page":"394","article-title":"Is population screening for cystic fibrosis appropriate now?","volume":"46","author":"Gilbert","year":"1990","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.socscimed.2020.112924_bib16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/healthcare3030830","article-title":"Genomics in public health: perspective from the office of public health genomics at the Centers for disease control and prevention (CDC)","volume":"3","author":"Green","year":"2015","journal-title":"Healthcare"},{"issue":"11","key":"10.1016\/j.socscimed.2020.112924_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/GIM.0b013e318159a331","article-title":"The cystic fibrosis mutation \u201carms race\u201d: when less is more","volume":"9","author":"Grody","year":"2007","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.socscimed.2020.112924_bib18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/clinchem\/45.5.746","article-title":"The role of Food and Drug Administration regulation of in vitro diagnostic devices\u2014Applications to genetics testing","volume":"45","author":"Gutman","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.socscimed.2020.112924_bib19","series-title":"Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease","first-page":"217","article-title":"ACCE: a model process for evaluating data on emerging genetic tests","author":"Haddow","year":"2003"},{"issue":"5","key":"10.1016\/j.socscimed.2020.112924_bib20","article-title":"Open sharing of genomic data: who does it and why?","volume":"1","author":"Haeusermann","year":"2017","journal-title":"PLOS"},{"key":"10.1016\/j.socscimed.2020.112924_bib21","series-title":"Genetic Testing: Predicting Disease or Diagnosis for Disaster? One Hundred Second Congress","author":"House Subcommittee on Human Resources and Intergovernmental Relations","year":"1993"},{"key":"10.1016\/j.socscimed.2020.112924_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.socscimed.2015.01.023","article-title":"Neoliberal technocracy: explaining how and why the US Food and Drug Administration has championed pharmacogenomics","volume":"131","author":"Hogarth","year":"2015","journal-title":"Soc. Sci. Med."},{"issue":"3","key":"10.1016\/j.socscimed.2020.112924_bib23","first-page":"555","article-title":"FDA regulation of genetic testing: institutional reluctance and public guardianship","volume":"53","author":"Huang","year":"1998","journal-title":"Food Drug Law J."},{"key":"10.1016\/j.socscimed.2020.112924_bib24","series-title":"Assessing Genetic Risks: Implications for Health and Social Policy","article-title":"Committee on assessing genetic risks","author":"Institute of Medicine (IOM)","year":"1994"},{"issue":"4","key":"10.1016\/j.socscimed.2020.112924_bib25","first-page":"617","article-title":"In search of a coherent framework: options for FDA oversight of genetic tests","volume":"62","author":"Javitt","year":"2007","journal-title":"Food Drug Law J."},{"issue":"6","key":"10.1016\/j.socscimed.2020.112924_bib26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0022-3476(88)80563-8","article-title":"Genetic counseling using linked DNA probes: cystic fibrosis as a prototype","volume":"113","author":"Johnson","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.socscimed.2020.112924_bib27","series-title":"Politics and the Architecture of Choice: Bounded Rationality and Governance","author":"Jones","year":"2001"},{"issue":"4922","key":"10.1016\/j.socscimed.2020.112924_bib28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.socscimed.2020.112924_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1467-9566.2005.00462.x","article-title":"Understanding genetic disease in socio-historical context: a case study of cystic fibrosis","volume":"27","author":"Kerr","year":"2005","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2020.112924_bib30","series-title":"Moments of Truth in Genetic Medicine","author":"Lindee","year":"2005"},{"issue":"4","key":"10.1016\/j.socscimed.2020.112924_bib31","first-page":"1211","article-title":"Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards","volume":"71","author":"Malinowski","year":"1997","journal-title":"Tulane Law Rev."},{"issue":"8","key":"10.1016\/j.socscimed.2020.112924_bib32","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2307\/1073689","article-title":"The architecture of government regulation of medical products","volume":"82","author":"Merrill","year":"1996","journal-title":"Va. Law Rev."},{"issue":"2","key":"10.1016\/j.socscimed.2020.112924_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10739-016-9437-8","article-title":"Screening out controversy: human genetics, emerging techniques of diagnosis, and the origins of the social issues committee of the American society of human genetics, 1964\u20131973","volume":"50","author":"Mitchell","year":"2017","journal-title":"J. Hist. Biol."},{"key":"10.1016\/j.socscimed.2020.112924_bib34","series-title":"Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era","first-page":"60","article-title":"Genetic exceptionalism and \u201cfuture diaries\u201d: is genetic information different from other medical information?","author":"Murray","year":"1997"},{"key":"10.1016\/j.socscimed.2020.112924_bib35","series-title":"Proposal No.90-233a: Predicting Future Disease: Issues in the Development, Application, and Use of Tests for Genetic Disorders","year":"1990"},{"issue":"1","key":"10.1016\/j.socscimed.2020.112924_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199007053230130","article-title":"Special report: statement from the national Institutes of health workshop on population screening for the cystic fibrosis gene","volume":"323","author":"National Institutes of Health","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.socscimed.2020.112924_bib37","first-page":"4539","article-title":"Proposed recommendations of the Task Force on genetic testing; notice of meeting and request for comment","volume":"62","author":"National Institutes of Health","year":"1997","journal-title":"Fed. Regist."},{"key":"10.1016\/j.socscimed.2020.112924_bib38","author":"National Institutes of Health"},{"issue":"5","key":"10.1016\/j.socscimed.2020.112924_bib39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-3476(88)80682-6","article-title":"Prenatal diagnosis and carrier detection of genetic diseases by analysis of deoxyribonucleic acid","volume":"112","author":"Ostrer","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.socscimed.2020.112924_bib40","series-title":"Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care","author":"Parthasarathy","year":"2007"},{"issue":"1","key":"10.1016\/j.socscimed.2020.112924_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S0898030600005844","article-title":"From eugenics to medical genetics","volume":"9","author":"Paul","year":"1997","journal-title":"J. Pol. Hist."},{"key":"10.1016\/j.socscimed.2020.112924_bib42","series-title":"The PKU Paradox: A Short History of a Genetic Disease","author":"Paul","year":"2013"},{"issue":"12","key":"10.1016\/j.socscimed.2020.112924_bib43","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/clinchem\/36.12.2027","article-title":"Clinical laboratory regulation under the clinical laboratory improvement Amendments of 1988: can it be done?","volume":"36","author":"Peddecord","year":"1990","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.socscimed.2020.112924_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41431-018-0095-5","article-title":"How is genetic testing evaluated? A systematic review of the literature","volume":"26","author":"Pitini","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.socscimed.2020.112924_bib45","series-title":"Screening and Counseling for Genetic Conditions: A Report on the Ethical, Social, and Legal Implications of Genetic Screening, Counseling, and Education Programs","author":"President\u2019s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research","year":"1983"},{"issue":"1","key":"10.1016\/j.socscimed.2020.112924_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02832235","article-title":"Frame-critical policy analysis and frame-reflective policy practice","volume":"9","author":"Rein","year":"1996","journal-title":"Knowl. Pol."},{"issue":"4922","key":"10.1016\/j.socscimed.2020.112924_bib47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"issue":"4948","key":"10.1016\/j.socscimed.2020.112924_bib48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.2315698","article-title":"CF screening delayed for awhile, perhaps forever","volume":"247","author":"Roberts","year":"1990","journal-title":"Science"},{"issue":"4922","key":"10.1016\/j.socscimed.2020.112924_bib49","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.socscimed.2020.112924_bib50","first-page":"470","article-title":"Screening for cystic fibrosis carriers","volume":"47","author":"Schulman","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.socscimed.2020.112924_bib51","author":"Secretary\u2019s Advisory Committee on Genetic Testing (SACGT)"},{"issue":"5","key":"10.1016\/j.socscimed.2020.112924_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/intqhc\/mzl034","article-title":"A multi-dimensional model of clinical utility","volume":"18","author":"Smart","year":"2006","journal-title":"Int. J. Qual. Health Care"},{"key":"10.1016\/j.socscimed.2020.112924_bib53","series-title":"Telling Genes: the Story of Genetic Counseling in America","author":"Stern","year":"2012"},{"issue":"1","key":"10.1016\/j.socscimed.2020.112924_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GIM.0b013e318184137c","article-title":"The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group","volume":"11","author":"Teutsch","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.socscimed.2020.112924_bib56","first-page":"4","article-title":"Beyond clinical utility: the multiple values of DTC genetics","volume":"8","author":"Turrini","year":"2016","journal-title":"Appl. Transl. Genom."},{"key":"10.1016\/j.socscimed.2020.112924_bib57","series-title":"The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay-Sachs, Cystic Fibrosis, and Sickle Cell Disease","author":"Wailoo","year":"2008"},{"issue":"20","key":"10.1016\/j.socscimed.2020.112924_bib58","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1001\/jama.1990.03440200081027","article-title":"The cystic fibrosis gene: medical and social implications for heterozygote detection","volume":"263","author":"Wilfond","year":"1990","journal-title":"J. Am. Med. Assoc."},{"issue":"24","key":"10.1016\/j.socscimed.2020.112924_bib59","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1001\/jama.1993.03510240060033","article-title":"National policy development for the clinical application of genetic diagnostic technologies: lessons from cystic fibrosis","volume":"270","author":"Wilfond","year":"1993","journal-title":"J. Am. Med. Assoc."},{"issue":"17","key":"10.1016\/j.socscimed.2020.112924_bib60","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.1987.03400170090028","article-title":"DNA probes: fruits of the new biotechnology","volume":"258","author":"Young","year":"1987","journal-title":"J. Am. Med. Assoc."}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027795362030143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027795362030143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:48:35Z","timestamp":1759506515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027795362030143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":58,"alternative-id":["S027795362030143X"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2020.112924","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Framing utility: Regulatory reform and genetic tests in the USA, 1989\u20132000","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2020.112924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112924"}}